Mucha-Habermann&apos;s disease in children: treatment with erythromycin

Shavin, J.S.; Jones, T.M.; Aton, J.K.; Abele, D.C.; Smith, J.G.; Shavin, J.S; Jones, T.M; Aton, J.K; Abele, D.C; Smith, J.G

Home

>

Node

>

Subnode

Mucha-Habermann's disease in children: treatment with erythromycin

Shavin, J.S.; Jones, T.M.; Aton, J.K.; Abele, D.C.; Smith, J.G.

Archives of Dermatology 114(11): 1679-1680

1978

ISSN/ISBN: 0003-987X

PMID: 718218

Document Number: 132010

Safe therapeutic measures for Mucha-Habermann's disease in children are lacking. Three patients with the disease were treated with erythromycin for systemic effect. Although the series is small and uncontrolled, this approach seemed effective. An anti-inflammatory mechanism related to inhibition of chemotaxis is speculated.